Raavi Gupta

Raavi Gupta, MD is a Professor in the Department of Pathology at SUNY Downstate Medical Center, specializing in the Division of Surgical Pathology and Hematopathology. She currently serves as President of the Medical Staff of SUNY Downstate Medical Center for the term 2023-2025. Her office is located at A2-406A, and she can be contacted at Raavi.Gupta@downstate.edu or by phone at (718) 270-1673.

Dr. Gupta's research interests focus on hematopoietic neoplasms including myelodysplastic syndrome and the biology of cancer in different ethnic populations. Her work emphasizes understanding racial disparities in cancer outcomes, particularly among African American patients. She has established expertise in molecular pathology, cancer genomics, and the application of artificial intelligence in diagnostic pathology.

Analysis of Dr. Gupta's recent publications (2021-2025) reveals a strong research trajectory focusing on health disparities in cancer, with particular emphasis on breast cancer, prostate cancer, and cervical cancer in minority populations. Her work increasingly incorporates artificial intelligence and computational approaches to pathology diagnosis, while maintaining a strong foundation in molecular biomarkers and hematopathology. A significant portion of her research addresses the biological basis for outcome disparities in African American cancer patients.

Dr. Gupta has secured substantial research funding as both Principal Investigator and Co-Investigator on multiple projects. She currently leads a Department of Defense-funded project (W81XWH-20-PCRP-HDRA) examining genomic differences in prostate cancer among African American men, and serves as Co-Investigator on an NIH project (5R01CA249667-02) investigating CDK4 inhibitory response markers in breast cancer. Previous funding includes projects from NIH Health Disparities Seed Funding Program and miR Diagnostics, all focused on cancer disparities and novel diagnostic approaches, particularly for underserved populations.

Though specific laboratory information isn't detailed in the provided text, Dr. Gupta's extensive collaborative network is evident through her numerous multi-institutional publications. Her research team appears to integrate pathologists, oncologists, molecular biologists, and data scientists to address complex questions in cancer biology and health disparities.